Ignite Creation Date:
2024-05-06 @ 11:01 AM
Last Modification Date:
2024-10-26 @ 12:38 PM
Study NCT ID:
NCT03403777
Status:
COMPLETED
Last Update Posted:
2019-03-05
First Post:
2018-01-02
Brief Title:
Avelumab in Refractory Testicular Germ Cell Cancer
Sponsor:
National Cancer Institute Slovakia
Organization:
National Cancer Institute Slovakia
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-11-15
Start Date Type:
ACTUAL
Primary Completion Date:
2019-02-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-02-28
Completion Date Type:
ACTUAL
First Submit Date:
2018-01-02
First Submit QC Date:
January 11 2018
Study First Post Date:
2018-01-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-03-03
Last Update Post Date:
2019-03-05
Last Update Post Date Type:
ACTUAL